Evidence map›Paper›PMID 39633519›Full record

ArticleCurrent vascular pharmacology2025

Response to the Letter to the Editor: Rare Endocrine Disorders and Peripheral Arterial Disease.

Mojca Jensterle, Ales Blinc, Dimitri P Mikhailidis, Panagiotis Anagnostis, Gerit-Holger Schernthaner, Pier Luigi Antignani, Katica Bajuk Studen, Miso Sabovic, Pavel Poredos

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Current vascular pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mojca JensterleDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Ales BlincFaculty of Medicine, Department of Internal Medicine, University of Ljubljana, Ljubljana, Slovenia.
Dimitri P MikhailidisDepartment of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London Medical School, University College London.
Panagiotis AnagnostisUnit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Gerit-Holger SchernthanerDepartment of Medicine 2, Division of Angiology, Medical University of Vienna, Vienna, Austria.
Pier Luigi AntignaniVascular Centre Nuova Villa Claudia, Rome, Italy.
Katica Bajuk StudenFaculty of Medicine, Department of Internal Medicine, University of Ljubljana, Ljubljana, Slovenia.
Miso SabovicFaculty of Medicine, Department of Internal Medicine, University of Ljubljana, Ljubljana, Slovenia.
Pavel PoredosFaculty of Medicine, Department of Internal Medicine, University of Ljubljana, Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39633519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.